桑苏止咳汤联合头孢丙烯治疗痰热壅肺证急性支气管炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R562.2+1

基金项目:

浙江省中医药科技计划项目(2023ZL680)


Clinical Study on Treatment of Acute Bronchitis with Phlegm-Heat Obstructing the Lung Syndrome Using Sangsu Zhike Decoction Combined with Cefprozil
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察桑苏止咳汤联合头孢丙烯治疗痰热壅肺证急性支气管炎的临床疗效及对血清炎症因子 水平的影响。方法:选取2022年8月—2024年8月浙江中医药大学附属湖州中医院收治的86例急性支气管炎 患者,按照随机数字表法分为西药组和联合组各43例。西药组给予头孢丙烯口服治疗,联合组给予桑苏止咳 汤联合头孢丙烯口服治疗,比较2组临床疗效、症状消失时间、肺功能、炎症因子指标[血清C-反应蛋白 (CRP)、白细胞介素-8 (IL-8) 及触珠蛋白(Hp)] 水平。结果:治疗后,联合组总有效率为95.35% (41/ 43),西药组为79.07%(34/43),2组比较,差异有统计学意义(P<0.05)。治疗后,联合组发热、咳嗽、肺部 湿啰音消失时间均早于西药组,差异有统计学意义(P<0.05)。治疗后,2组潮气量较治疗前升高(P<0.05), 呼吸频率、达峰时间比均较治疗前下降(P<0.05);且联合组潮气量高于西药组(P<0.05),呼吸频率、达峰 时间比均低于西药组(P<0.05)。治疗后,2组CRP、IL-8、Hp水平均较治疗前降低(P<0.05),且联合组 3项指标水平均低于西药组(P<0.05)。结论:桑苏止咳汤联合头孢丙烯治疗痰热壅肺证急性支气管炎可进一 步提升疗效,改善肺功能,减轻炎症反应,加速病情康复。

    Abstract:

    Abstract: Objective: To observe the clinical efficacy of Sangsu Zhike Decoction combined with Cefprozil in treating acute bronchitis with phlegm-heat obstructing the lung syndrome and its impact on serum inflammatory factor levels. Methods: A total of 86 patients with acute bronchitis treated at Huzhou TCM Hospital Affiliated to Zhejiang Chinese Medical University from August 2022 to August 2024 were selected and divided into a western medicine group and a combined treatment group, with 43 cases in each group, using the random number table method. The western medicine group received oral Cefprozil treatment,while the combined treatment group received Sangsu Zhike Decoction combined with oral Cefprozil treatment. Clinical efficacy was compared between the two groups,as well as changes in symptom disappearance time, pulmonary function, and inflammatory factor indicators [serum C-reactive protein (CRP),interleukin-8(IL-8),and haptoglobin(Hp)levels] before and after treatment. Results:After treatment, the total effective rate in the combined treatment group was 95.35%(41/43),which was higher than that in the western medicine group at 79.07%(34/43),with a statistically significant difference between the two groups(P<0.05). After treatment, the combined treatment group showed earlier disappearance of fever, cough, and pulmonary rales compared with the western medicine group, with statistically significant differences(P<0.05). After treatment, the tidal volume increased in both groups compared to before treatment(P<0.05), with the combined treatment group achieving higher values than the western medicine group(P<0.05);the respiratory rate and peak time ratio decreased in both groups compared to before treatment(P<0.05),with the combined treatment group having a lower respiratory rate and peak time ratio than the western medicine group(P<0.05). After treatment,the levels of CRP,IL-8,and Hp decreased in both groups compared to before treatment(P<0.05), with the combined treatment group achieving lower levels of these indicators than the western medicine group(P<0.05). Conclusion: Sangsu Zhike Decoction combined with Cefprozil in treating acute bronchitis with phlegm-heat obstructing the lung syndrome can further enhance therapeutic effects,improve pulmonary function,reduce inflammatory responses,and accelerate disease recovery.

    参考文献
    相似文献
    引证文献
引用本文

王春子,姚运豪,代云芸,李峥嵘,李雪,毛伟.桑苏止咳汤联合头孢丙烯治疗痰热壅肺证急性支气管炎临床研究[J].新中医,2025,57(20):34-38

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-10-31
  • 出版日期:
文章二维码